This insider cluster is routine and non-informative, no C-suite participation, trivial dollar amounts relative to market cap, and the derivative exercise pattern is standard. No trading action warranted. Monitor next 10-Q for any fundamental changes, but this filing has no standalone signal.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Aug 31 $90.75entry
- T+1 · 3mo ago −0.01%α +0.68% · $90.74
- T+5 · 2mo ago −4.44%α −4.30% · $86.72
- T+20 · 7w ago −2.94%α −2.57% · $88.08
- T+54 · todayOpen
- T+60 · in 7d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Edwards Lifesciences corporate VPs (CVP) sold a total of ~$457K in open-market sales over a 3-day window, with Daveen Chopra also exercising and immediately selling 31,800 derivative shares for ~$2.8M. At a $51.8B market cap, the open-market sales represent ~0.0009% of market cap, trivial and routine. Chopra's derivative exercise-and-sell is a standard cashless exercise pattern, not a bearish signal. The cluster is non-informative.
Key Financial Metrics
Key Facts
- Three corporate VPs sold open-market shares totaling ~$457K, representing ~0.0009% of EW's $51.8B market cap
- Daveen Chopra (CVP, TMTT, Surgical & IHFM) exercised 31,800 derivative shares at $72.68 and immediately sold 30,646 shares at ~$90.99 for ~$2.79M, a standard cashless exercise pattern
- No C-suite executives (CEO/CFO) participated in the cluster
- All sales occurred within a 3-day window (Aug 26-28, 2026), consistent with a shared blackout-window opening or vesting schedule
Financial Impact
Open-market sales of ~$457K are immaterial for a $51.8B company; Chopra's derivative exercise-and-sale of ~$2.8M is a non-cash event with no net economic impact
Risk Factors
- No material risk identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-EW-1787983325991 |
Track record
27 reports on EW
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +4.94% at T+5 after the Nov 4, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 3/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $100.82 to $105.80 Now $107.11 +6.24% ▲ +4.94% +1.65% vs SPY
- Oct 29, 202618d ago Institutional Cluster Neutral 3/10 Entry $94.44 to $100.82 Now $107.11 +13.42% ▲ +6.76% +11.48% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $90.74 to $86.18 Now $107.11 +18.04% ▼ −5.03% −5.11% vs SPY
- Aug 28, 202611w ago Insider Cluster Neutral 2/10 Viewing Entry $90.75 to $86.72 Now $107.11 +18.03% ▼ −4.44% −4.30% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers